ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 996

Metabolic Control of Invariant Natural Killer T Cell Function

Kevin Wei1, Deepak A. Rao2, Pui Y. Lee3, Anqi Gao4, Peter A. Nigrovic5 and Michael Brenner6, 1Rheumatology, Immunology & Allergy, Brigham & Women's Hospital, Boston, MA, 2Internal Medicine/Rheumatology, Brigham & Womens Hospital, Boston, MA, 3Division of Immunology, Boston Children's Hospital, Boston, MA, 4Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA, 5Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 6Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: T cells and metabolism

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: T cell Biology and Targets in Autoimmune Disease I

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose:

Invariant Natural Killer T (iNKT) cells are a unique subset of T cells that shape an inflammatory response through rapid production of large amounts of cytokines following activation.  Perturbation in frequency and proliferative response of peripheral blood iNKT cells have been described in rheumatoid arthritis and systemic lupus erythematosus, however the mechanism is not well understood.  Metabolic reprogramming from oxidative phosphorylation to aerobic glycolysis is crucial for T cell proliferation and cytokine production.  The aim of this study is to characterize metabolic reprogramming during iNKT cell activation. 

Methods:

Peripheral blood iNKT cell frequency from rheumatoid arthritis patients and healthy controls were measured by flow cytometry.  Cultured mouse iNKT cells were used for metabolic analysis.  iNKT cell oxygen consumption and extracellular acidification were measured using a Seahorse XFe24 analyzer. Specific pharmacologic inhibitors 2-deoxyglucose (glycolysis) and oligomycin (oxidative phosphorylation) tested specific metabolic pathways for iNKT cell function.

Results:

Compared with healthy controls, rheumatoid arthritis patients had a decreased frequency of peripheral blood iNKT cells.  Metabolic analysis of murine iNKT cell revealed predominant reliance on oxidative phosphorylation at basal state.  Upon stimulation with the cognate lipid antigen alpha-galactosylceramide, iNKT cells exhibit significantly enhanced glycolysis and glycolytic capacity.  In contrast, oxidative phosphorylation was only modestly elevated while spare respiratory capacity was suppressed following activation.  Glycolysis, but not oxidative phosphorylation, has been shown to be essential for interferon-gamma production in MHC-restricted T-cells.  In contrast, inhibition of either glycolysis or oxidative phosphorylation in iNKT cells resulted in dose-dependent suppression of interferon-gamma production, suggesting differential metabolic control in iNKT cells   

Conclusion:

In summary, peripheral blood iNKT cells are significantly reduced in rheumatoid arthritis patients.  Our data suggest that metabolic reprogramming and glucose utilization play a crucial role in iNKT cell function.  Further characterization of iNKT cell metabolic state in rheumatoid arthritis patients may shed light on mechanisms of altered iNKT cell function during chronic inflammation.


Disclosure: K. Wei, None; D. A. Rao, None; P. Y. Lee, None; A. Gao, None; P. A. Nigrovic, None; M. Brenner, None.

To cite this abstract in AMA style:

Wei K, Rao DA, Lee PY, Gao A, Nigrovic PA, Brenner M. Metabolic Control of Invariant Natural Killer T Cell Function [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/metabolic-control-of-invariant-natural-killer-t-cell-function/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/metabolic-control-of-invariant-natural-killer-t-cell-function/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology